Home > Insider Trading > Filing (0001104659-16-121929)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1621227	Adaptimmune Therapeutics Plc	ADAP	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661908	Elliott Charles Sigal	32 Brearly Road Princeton NJ 08540		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	Acquisiton	2016-05-16	15,000	$1.50	269,100	No	4	P	Indirect	Shares held by Sigal Family Investments, LLC
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	Acquisiton	2016-05-17	15,000	$1.53	284,100	No	4	P	Indirect	Shares held by Sigal Family Investments, LLC
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	Acquisiton	2016-05-18	15,000	$1.55	299,100	No	4	P	Indirect	Shares held by Sigal Family Investments, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Shares held by Sigal Family Investments, LLC
No	4	P	Indirect	Shares held by Sigal Family Investments, LLC
No	4	P	Indirect	Shares held by Sigal Family Investments, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	52,938	Direct

Footnotes

Dr. Sigal is a manager of Sigal Family Investments, LLC. Dr. Sigal may be deemed to have voting and investment power over the shares held by Sigal Family Investments, LLC. Dr. Sigal disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The 15,000 Ordinary Shares are represented by 2,500 American Depositary Shares ("ADSs") which are held by Sigal Family Investments, LLC. Each ADS represents six Ordinary Shares of Adaptimmune Therapeutics plc.
The price of $1.50 per Ordinary Share was derived from the purchase price paid on May 16, 2016, of $8.98 per ADS, divided by six.
The 269,100 Ordinary Shares comprise (i) 254,100 Ordinary Shares, and (ii) 15,000 Ordinary Shares represented by 2,500 ADSs.
The price of $1.53 per Ordinary Share was derived from the purchase price paid on May 17, 2016, of $9.18 per ADS, divided by six.
The 284,100 Ordinary Shares comprise (i) 254,100 Ordinary Shares, and (ii) 30,000 Ordinary Shares represented by 5,000 ADSs.
The price of $1.55 per Ordinary Share was derived from the purchase price paid on May 18, 2016, of $9.30 per ADS, divided by six.
The 299,100 Ordinary Shares comprise (i) 254,100 Ordinary Shares, and (ii) 45,000 Ordinary Shares represented by 7,500 ADSs.
The 52,938 Ordinary Shares are represented by 8,823 ADSs.